Adverse events reporting—the tip of an icebergFootnote*

Presented in‐part at the National Conference on: ‘The Business of Human Experiments, ethical, legal, and regulatory issues,”; November 3–5, 2000, Baltimore, Maryland. Tel: (410) 706–3327. Fax: (410) 706–3189. E‐mail: [email protected].

References

• Advisory Committee on Human Radiation Experiments (ACHRE) . October 1995 . Final Report , October , Washington, D.C. : U.S. Government Printing Office .
   Google Scholar
• Black , H. 2000 . “Research and Human Subjects Recent Temporary Suspensions, Regulation Initiative, Inject Uncertainty into Study Management.” . The Scientist , 14 ( 19 ) Oct. 2 : 1
   Google Scholar
• Brainard , J. 2000 . “Will a ‘Fresh Face’ Bring a New Approach to Federal Protection of Human Subjects?” . Chronicle of Higher Education , July 21 2000
   Google Scholar
• Brennan , T.A. 2000 . “Sounding Board—The Institute of Medicine Report on Medical Errors—Could it Do Harm?” . New England J. Medicine , 342 : 1123 – 1125 .
   PubMed Web of Science ®Google Scholar
• Center Watch (2000). http://www.centerwatch.com (http://www.centerwatch.com)
   Google Scholar
• Code of Federal Regulations (CFR) (1998). 21 part 56.
   Google Scholar
• Code of Federal Regulations (CFR) (1991). 45 Part 46
   Google Scholar
• Code of Federal Regulation (CFR) (1981). 45 Part 46
   Google Scholar
• Gorovitz , H. and Gorovitz , S. 2000 . “Pesticide Toxicity, Human Subjects, and the Environmental Protection Agency's Dilemma.” . The Journal of Contemporary Health Law and Policy , 16 : 427 – 458 .
   PubMedGoogle Scholar
• http://www.salon.com/health/feature/2000/08/18/human‐subject/print.htm (http://www.salon.com/health/feature/2000/08/18/human‐subject/print.htm)
   Google Scholar
• Khan , A. , Warner , H.A. and Brown , W.A. 2000 . “Symptoms Reduction and Suicide Risk in Patients Treated with Placebo in Antidepressants Clinical Trials.” . Arch. Gen. Psych. , 57 : 311 – 317 .
   PubMed Web of Science ®Google Scholar
• Kohn , L.T. , Corrigan , J.M. and Donaldson , M.S. , eds. 2000 . “ ‘To Err is human—Building a Safer Health System,” . In Committee on Quality of Health Case in America, Institute of Medicine , 1 – 287 . Washington, D.C. : National Academy Press .
   Google Scholar
• Lazarou , J. , Pomeranz , B.H. and Corey , P.N. 1998 . “Incidence of Adverse Drug Reaction in Hospitalized Patients—A Meta‐Analysis of Prospective Studies.” . JAMA , 279 : 1200 – 1205 .
   PubMed Web of Science ®Google Scholar
• Malakoff , D. 2000 . “Flawed Cancer Study Leads to Shake‐up at University of Oklahoma.” . Science , 289 : 706 – 707 .
   PubMed Web of Science ®Google Scholar
• Marshal , E. 1999 . “NIMH to screen studies for science and human risks.” . Science , 283 : 464 – 5 .
   PubMed Web of Science ®Google Scholar
• Merck, Manual website (2000). http://www.merck.com/pubs/mmanual/section15/ chapter190/ 190a.htm (http://www.merck.com/pubs/mmanual/section15/ chapter190/ 190a.htm)
   Google Scholar
• National Bioethics Advisory Commission . 1998 . “Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity.” . 1 December : 1 – 88 .
   Google Scholar
• National Center for Health Statistics (NCHS) (1998). http://www.cdc.gov/nchsw‐ww/datawh/statab/pubd/47–17.htm (http://www.cdc.gov/nchsw‐ww/datawh/statab/pubd/47–17.htm)
   Google Scholar
• Nelson , D. and Weiss , R. 2000 . “Gene Test Deaths Not Reported Promptly.” . The Washington Post , Jan. 31 : A1
   PubMedGoogle Scholar
• NIH (2000) website: http://hhs.gov/progorg/asmb/budget/fy99budget/pdffiles/ nihl.pdf (website: http://hhs.gov/progorg/asmb/budget/fy99budget/pdffiles/ nihl.pdf)
   Google Scholar
• National Science Foundation (NSF) . 2000 . Science and Engineering Indicators‐2000 (NSB00–1) Arlington, VA. It can be also accessed through NSF web or government websites
   Google Scholar
• Office for Human Research Protections (OHRP) . (2000). FOIA case ID: 25214, August 18, 2000 letter to A.E. Shamoo from Barry W. Boman (FIOA Coordinator). The letter contained: (1) A list of Compliance Oversight Branch Investigations (COBIs) resulting in restrictions/actions to Multiple Project Assurances, from January 1990 to June 2000; and (2) A list of all Institutional Incident Reports (IRPTs) from January 1990 to August 18, 2000
   Google Scholar
• Office of Protection from Research Risks, “Letter of March 22, 1999, from OPRR in VA Greater Los Angeles Healthcare System.”
   Google Scholar
• Pharma . 2000 . Annual Report (www.pharma.org)
   Google Scholar
• Prentice , E.D. and Gorson , B. 1997 . “ IRB Reviews of Adverse Events in Investiga‐tional Drug Studies.” . IRB , 19 : 1 – 4 .
   PubMedGoogle Scholar
• Public Law (PL) 93–348, July 12, 1974
   Google Scholar
• Rezendes , VS. 2000 . “VA Research System for protecting Human Subjects Needs Improvement,” . In GAO Statement before the Subcommittee on Oversight & Investigations,. Committee on Veterans’ Affairs, House of Representatives http://veter‐ns.house.gov/hearings/schedule106/sept00/9–28–00/gao.htm
   Google Scholar
• Roth , C , Pinn , V.W. , Bates , A. and Faming , L. May 2000 . NIH Tracking/Inclusion Committee, Implementation of the NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, FY 1997 , Second Revision May , 1 – 24 . 2000
   Google Scholar
• Shamoo , A.E. 2000 . “Future Challenges to Human Subjects Protection.” . The Scientist , June 26 : 35
   Web of Science ®Google Scholar
• Shamoo , A.E. 1999a . Accountability in Research , 7 ( [2—4] ) : 101 – 309 .
   PubMedGoogle Scholar
• Shamoo , A.E. 199b . “ ‘The Unethical Use of Human Beings in High Risk Research Experiments,” . In Testimony to the April 21, 1999 Joint Hearing before Subcommittee on Oversight and Investigations and Subcommittee on Health of the Committee on Veterans’ Affairs , House of Representatives, Serial No. 106–10 Washington, D.C. : U.S. Government Printing Office . 2000, ISBN 0–16–060247–5
   Google Scholar
• Shamoo , A.E. 1999 . “Institutional Review Boards (IRBs) and Conflict of Interest.” . Accountability in Research , 7 : 201 – 212 .
   PubMedGoogle Scholar
• Shamoo , A.E and Sharav , V.H. 1997 . “Unethical Use of Persons with Mental Illness in High Risk Research Experiments.” . BioLaw , II : S23 – S31 .
   Google Scholar
• Shamoo , A.E. , ed. 1997 . “Ethics in Neurobiological Research with Human Subjects” . 1 – 335 . Amsterdam, B.V., , The Netherlands : Gordon and Breach Publishers OPA .
   Google Scholar
• Shamoo , A.E. , Irving , D.N. and Langenberg , P. 1997 . “A Review of Patient Outcomes in Pharmacological Studies from the Psychiatric Literature, 1966–1993.” . Science and Engineering Ethics , 3 : 395 – 406 .
   PubMedGoogle Scholar
• Shamoo , A.E. and Irving , D.N. 1993 . “Accountability in Research Using Persons with Mental Illness.” . Accountability in Research , 3 : 1 – 17 .
   PubMedGoogle Scholar
• Shamoo , A.E. and Keay , T. 1996 . “Ethical Concerns about Relapse Studies.” . Cambridge Quarterly of Health Care Ethics , 5 : 373 – 386 .
   PubMed Web of Science ®Google Scholar
• Sharav , V.H. and Shamoo , A.E. 2000a . “Lab Rats—Why do people who participate in clinical studies have fewer protections then animals?” .
   Google Scholar
• Sharav , V.H. and Shamoo , A.E. 2000b . “Are Experiments That Chemically Induce Psychosis in Patients Ethical?” . BioLaw , II ( 1 ) : S:1 – S:36 .
   Google Scholar
• Sharav , V.H. and Shamoo , A.E. February 2 1999a . “Unethical Human Experiments in Unwitting Patients,” . In Statement for the Record submitted to U.S. Senate Sub‐Committee, Public Health and Safety of the Senate Health, Education, Labor and Pensions Committee February 2 , 2000
   Google Scholar
• Sharav , V.H. and Shamoo , A.E. December 9 1999b . “The need for better protections for vulnerable groups when used in research experiments,” . In Testimony to Subcommittee on Criminal Justice, Drug Policy, and Human Resources, Committee on Government Reform , U.S. House of Representative, United States Government December 9 , New York, N.Y. : New York Lawyers Association . 1999
   Google Scholar
• Studdert , D.M. 2000 . “Negligent Care and Malpractice Claiming Behavior in Utah and Colorado.” . Medical Care , 38 : 250 – 260 .
   PubMed Web of Science ®Google Scholar
• Thomas , E.J. 2000 . “Incidence and Types of Adverse Events and Negligent Care in Utah and Colorado.” . Medical Care , 38 : 261 – 271 .
   PubMed Web of Science ®Google Scholar
• Thomas , EJ. 1999 . “Cost of Medical Injuries in Utah and Colorado.” . Inquiry , 36 : 255 – 264 .
   PubMed Web of Science ®Google Scholar
• Washington Post, The . 2000 . “Gene Therapy Run Amok?” . Editorial , : A18
   Google Scholar
• Weiss , R. 1999 . “Gene Therapy Firms Resist Publicity,” . The Washington Post , December 11 : A2
   PubMedGoogle Scholar
• Presented in‐part at the National Conference on: ‘The Business of Human Experiments, ethical, legal, and regulatory issues,”; November 3–5, 2000, Baltimore, Maryland. Tel: (410) 706–3327. Fax: (410) 706–3189. E‐mail: [email protected].
   Google Scholar